Literature DB >> 8772690

Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients.

A Benetos1, S Gautier, S Ricard, J Topouchian, R Asmar, O Poirier, E Larosa, L Guize, M Safar, F Soubrier, F Cambien.   

Abstract

BACKGROUND: Clinical and experimental studies have demonstrated a major role of the renin-angiotensin system in the functional and structural changes of the large arteries in hypertension. Because genetic studies may help us to understand the mechanisms underlying the involvement of this system in arterial regulation, the present study was designed to assess the contribution of polymorphisms of the ACE insertion/deletion (I/D) and angiotensin II type 1 receptor (AGTR1 A 1166C) genes on aortic stiffness regulation. METHODS AND
RESULTS: This study included 311 untreated hypertensive and 128 normotensive subjects. Aortic stiffness was evaluated by measurement of the carotid-femoral pulse-wave velocity (PWV). In normotensive subjects, the two polymorphisms did not influence any of the studied parameters. In hypertensive subjects, there was a decreasing trend of mean PWV with the number of ACE D alleles, but this association became significant only after adjustment for blood pressure (P < .05). Conversely, the AGTR1 A 1166C polymorphism was independently associated with aortic stiffness. Mean values of PWV were 11.6 +/- 2.7 m/s in AGTR1 AA homozygotes, 13.3 +/- 3.3 m/s in AC heterozygotes, and 15.3 +/- 4.3 m/s in CC homozygotes (P < .0001 and P < .00001 after adjustment for age and mean blood pressure, respectively). The percentage of variance of PWV explained by AGTR1 A 1166C polymorphism (11.6%) was much larger than that of ACE I/D polymorphism (1.7%).
CONCLUSIONS: These results suggest that in hypertensive but not normotensive subjects, the AGTR1 and ACE genotypes are involved in the regulation of aortic rigidity. The presence of the AGTR1 C allele is a strong independent determinant of aortic stiffness, whereas presence of the ACE 1 allele is weakly associated with increased stiffness.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8772690     DOI: 10.1161/01.cir.94.4.698

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  39 in total

Review 1.  Angiotensin I-converting enzyme: genotype and disease associations.

Authors:  D Crisan; J Carr
Journal:  J Mol Diagn       Date:  2000-08       Impact factor: 5.568

Review 2.  Genetic determinants of vascular reactivity.

Authors:  Daniel Henrion; Joelle Benessiano; Marc Iglarz; Ivan Philip; Bernard I Levy
Journal:  Curr Hypertens Rep       Date:  2002-02       Impact factor: 5.369

Review 3.  The need to lower systolic blood pressure.

Authors:  S Shrivastava; M S Kochar
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

4.  Trisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteins.

Authors:  Terry S Elton; Sarah E Sansom; Mickey M Martin
Journal:  RNA Biol       Date:  2010-09-01       Impact factor: 4.652

Review 5.  Translational study of microRNAs and its application in kidney disease and hypertension research.

Authors:  Alison J Kriegel; Domagoj Mladinov; Mingyu Liang
Journal:  Clin Sci (Lond)       Date:  2012-05-01       Impact factor: 6.124

6.  Common genetic variation in the 3'-BCL11B gene desert is associated with carotid-femoral pulse wave velocity and excess cardiovascular disease risk: the AortaGen Consortium.

Authors:  Gary F Mitchell; Germaine C Verwoert; Kirill V Tarasov; Aaron Isaacs; Albert V Smith; Ernst R Rietzschel; Toshiko Tanaka; Yongmei Liu; Afshin Parsa; Samer S Najjar; Kevin M O'Shaughnessy; Sigurdur Sigurdsson; Marc L De Buyzere; Martin G Larson; Mark P S Sie; Jeanette S Andrews; Wendy S Post; Francesco U S Mattace-Raso; Carmel M McEniery; Gudny Eiriksdottir; Patrick Segers; Ramachandran S Vasan; Marie Josee E van Rijn; Timothy D Howard; Patrick F McArdle; Abbas Dehghan; Elizabeth S Jewell; Stephen J Newhouse; Sofie Bekaert; Naomi M Hamburg; Anne B Newman; Albert Hofman; Angelo Scuteri; Dirk De Bacquer; Mohammad Arfan Ikram; Bruce M Psaty; Christian Fuchsberger; Matthias Olden; Louise V Wain; Paul Elliott; Nicholas L Smith; Janine F Felix; Jeanette Erdmann; Joseph A Vita; Kim Sutton-Tyrrell; Eric J G Sijbrands; Serena Sanna; Lenore J Launer; Tim De Meyer; Andrew D Johnson; Anna F C Schut; David M Herrington; Fernando Rivadeneira; Manuela Uda; Ian B Wilkinson; Thor Aspelund; Thierry C Gillebert; Luc Van Bortel; Emelia J Benjamin; Ben A Oostra; Jingzhong Ding; Quince Gibson; André G Uitterlinden; Gonçalo R Abecasis; John R Cockcroft; Vilmundur Gudnason; Guy G De Backer; Luigi Ferrucci; Tamara B Harris; Alan R Shuldiner; Cornelia M van Duijn; Daniel Levy; Edward G Lakatta; Jacqueline C M Witteman
Journal:  Circ Cardiovasc Genet       Date:  2011-11-08

Review 7.  Arterial stiffness: from physiology to clinical implications.

Authors:  Alberto Milan; Francesco Tosello; Ambra Fabbri; Alessandro Vairo; Dario Leone; Michela Chiarlo; Michele Covella; Franco Veglio
Journal:  High Blood Press Cardiovasc Prev       Date:  2011-03-01

Review 8.  Genetics of hypertension. Therapeutic implications.

Authors:  S O'Byrne; M Caulfield
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

9.  Functional polymorphisms in genes of the Angiotensin and Serotonin systems and risk of hypertrophic cardiomyopathy: AT1R as a potential modifier.

Authors:  Eliecer Coto; María Palacín; María Martín; Mónica G Castro; Julián R Reguero; Cristina García; José R Berrazueta; César Morís; Blanca Morales; Francisco Ortega; Ana I Corao; Marta Díaz; Beatriz Tavira; Victoria Alvarez
Journal:  J Transl Med       Date:  2010-07-01       Impact factor: 5.531

10.  Cardiovascular Disease, Single Nucleotide Polymorphisms; and the Renin Angiotensin System: Is There a MicroRNA Connection?

Authors:  Terry S Elton; Sarah E Sansom; Mickey M Martin
Journal:  Int J Hypertens       Date:  2010-08-04       Impact factor: 2.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.